-
1 Comment
Fresenius SE & Co. KGaA is currently in a long term uptrend where the price is trading 12.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
Fresenius SE & Co. KGaA's total revenue sank by 0.1% to $9B since the same quarter in the previous year.
Its net income has dropped by 20.4% to $410M since the same quarter in the previous year.
Finally, its free cash flow grew by 28.9% to $562M since the same quarter in the previous year.
Based on the above factors, Fresenius SE & Co. KGaA gets an overall score of 3/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | DE0005785604 |
Sector | Healthcare |
Industry | Medical Care Facilities |
Beta | 1.0 |
---|---|
Target Price | 46.9933 |
Market Cap | 23B |
PE Ratio | 25.52 |
Dividend Yield | None |
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FRE.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025